ADVANCED CELL TECHNOLOGY
DEAD

Add to watchlist:

No watchlists yet
View on USPTO

ADVANCED CELL TECHNOLOGY Trademark

Serial Number: 75213708 • Registration: 2522890

ADVANCED CELL TECHNOLOGY is a trademark filed by ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE on December 16, 1996. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 31 (Natural Agricultural Products). The application is currently no longer active.

Owner Contact Info

ASTELLAS INSTITUTE FOR REGENERATIVE MEDICINE (25 trademarks)

33 LOCKE DRIVE
MARLBOROUGH, MA 01752

Entity Type: 03

OCATA THERAPEUTICS, INC. (18 trademarks)

33 LOCKE DRIVE
MARLBOROUGH, MA 01752

Entity Type: 03

Advanced Cell Technology, Inc. (14 trademarks)

33 Locke Drive
Marlborough, MA 01752

Entity Type: 03

Trademark Details

Filing Date

December 16, 1996

Registration Date

December 25, 2001

Published for Opposition

May 12, 1998

Cancellation Date

July 8, 2022

Goods & Services

[ genetically engineered organic matter for medical diagnostic use and for the treatment of a variety of human and animal diseases and conditions, (namely, neurological diseases and conditions, viral diseases and conditions, cancer, diseases and conditions treated by organ or tissue transplant), namely, embryos, sperm cells, eggs, animal parts, transgenic animal parts, monoclonal antibodies, cell lines, primordial germ cells, embryonic cells, embryonic tissues, fetal cells, fetal tissues, fetal organs, differentiated cells produced from embryonic cell lines, transgenic differentiated cells produced from embryonic cell lines, proteins or DNA's produced from transgenic animals; DNA constructs for medical diagnostic use and for the treatment of a variety of human and animal diseases and conditions, namely, neurological diseases and conditions, viral diseases and conditions, cancer, diseases and conditions treated by organ or tissue transplant; genetic markers for medical diagnostic use and for the treatment of a variety of human and animal diseases and conditions, namely, neurological diseases and conditions, viral diseases and conditions, cancer, diseases and conditions treated by organ or tissue transplant ]

[ genetically engineered organic matter for medical research, scientific research and agricultural research use, namely, embryos, sperm cells, eggs, animal parts, transgenic animal parts, monoclonal antibodies, cell lines, primordial germ cells, embryonic cells, embryonic tissues, fetal cells, fetal tissues, fetal organs, differentiated cells produced from embryonic cell lines, transgenic differentiated cells produced from embryonic cell lines, proteins or DNA's produced from transgenic animals; DNA constructs for medical research, scientific research and agricultural research use; genetic markers for medical research, scientific research and agricultural research use; cryopreservation kits comprised of cryoprotective solutions for use in freezing animal cells ]

[ transgenic living animals for laboratory use as livestock and for protein production; living animals for laboratory use as livestock and for protein production ]

biotechnology services, namely, [ cloning animals, ] producing differentiated cell types, [ which may be transgenic, ] producing embryonic stem cell lines, [ transgenic animals and proteins; ] all to the specification of others for research, medical, and agricultural use

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jul 8, 2022 CAEX
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Dec 25, 2020 REM2
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Nov 11, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Nov 11, 2019 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jun 29, 2016 ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Jan 21, 2015 ASGN
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 30, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 30, 2012 REAP
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Jan 5, 2012 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Jan 5, 2012 89AG
TEAS SECTION 8 & 9 RECEIVED
Dec 20, 2011 E89R
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jul 14, 2008 C15P
ASSIGNED TO PARALEGAL
Jul 2, 2008 PLGL
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jun 25, 2008 815F
TEAS SECTION 8 & 15 RECEIVED
Jun 25, 2008 E815
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 25, 2008 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 25, 2008 COAR
CASE FILE IN TICRS
Apr 25, 2007 CFIT
REGISTERED-PRINCIPAL REGISTER
Dec 25, 2001 R.PR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Aug 21, 2001 CNPR
ASSIGNED TO EXAMINER
Aug 21, 2001 DOCK
STATEMENT OF USE PROCESSING COMPLETE
Aug 16, 2001 SUPC
USE AMENDMENT FILED
Aug 4, 2001 IUAF
SOU EXTENSION 5 GRANTED
Mar 8, 2001 EX5G
SOU EXTENSION 5 FILED
Feb 4, 2001 EXT5
SOU EXTENSION 4 GRANTED
Sep 27, 2000 EX4G
SOU EXTENSION 4 FILED
Aug 4, 2000 EXT4
SOU EXTENSION 3 GRANTED
Apr 4, 2000 EX3G
SOU EXTENSION 3 FILED
Feb 4, 2000 EXT3
SOU EXTENSION 2 GRANTED
Aug 30, 1999 EX2G
SOU EXTENSION 2 FILED
Aug 4, 1999 EXT2
SOU EXTENSION 1 GRANTED
Feb 22, 1999 EX1G
SOU EXTENSION 1 FILED
Feb 3, 1999 EXT1
NOA MAILED - SOU REQUIRED FROM APPLICANT
Aug 4, 1998 NOAM
PUBLISHED FOR OPPOSITION
May 12, 1998 PUBO
PUBLISHED FOR OPPOSITION
May 12, 1998 PUBO
NOTICE OF PUBLICATION
Apr 10, 1998 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 19, 1998 CNSA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 9, 1998 CRFA
NON-FINAL ACTION MAILED
Jul 9, 1997 CNRT
ASSIGNED TO EXAMINER
Jul 3, 1997 DOCK